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An  alkaliphilic  actinomycete,  BCI-1,  was  isolated  from  soil  samples  collected  from  Saurashtra  University
campus,  Gujarat.  Isolated  strain  was  identiﬁed  as Streptomyces  werraensis  based on  morphological,  bio-
chemical  and  phylogenetic  analysis.  Maximum  antibiotic  production  was  obtained  in media  containing
sucrose  2%,  Yeast  extract  1.5%,  and  NaCl  2.5%  at pH  9.0  for 7 days  at 30 ◦C. Maximum  inhibitory  compound
was  produced  at  pH  9 and  at 30 ◦C. FTIR  revealed  imine,  amine,  alkane  (C  C)  of  aromatic  ring and  p-di  sub-
stituted  benzene,  whereas  HPLC  analysis  of  partially  puriﬁed  compound  and  library  search  conﬁrmed  95%ermentation
peaks matches  with  erythromycin.  Chloroform  extracted  isolated  compound  showed  MIC  values  1 g/ml
against  Bacillus  subtilis,  ≤0.5  g/ml  against  Staphylococcus  aureus,  ≤0.5  g/ml against  Escherichia  coli  and
2.0  g/ml  against  Serretia  GSD2  sp., which  is more  effective  in  comparison  to  ehtylacetate  and  methanol
extracted  compounds.  The  study  holds  signiﬁcance  as  only  few alkaliphilic  actinomycetes  have  been
explored  for  their  antimicrobial  potential.
© 2014  Published  by Elsevier  B.V.  This  is an  open  access  article  under  the  CC  BY-NC-ND  license. Introduction
Among the antibiotic producing microbes, the class Actinobac-
eria represents a broad range of valuable and prominent sources of
harmaceutically active metabolites. Actinomycetes are responsi-
le for the production of about half of the discovered secondary
etabolites [1], notably antibiotics [2], antitumour agents [3],
mmunosuppressive agents [4] and enzymes [5]. Each actino-
ycetes strain has probably genetic potential for producing 10–20
econdary metabolites [6]. Terrestrial actinomycetes are one of the
bundant sources of secondary metabolites and the vast majority
f these compounds are derived from the single genus Strepto-
yces. Streptomyces are distributed widely in terrestrial and marine
abitats [7] and are of commercial interest due to their unique
apacity to produce novel metabolites. The genus Streptomyces
as classiﬁed under the family Streptomycetaceae,  which includes
ram-positive aerobic members of the order Actinomycetales and
uborder Streptomycineae within the new class Actinobacteria [8,9].
hey produce approximately 75% of commercially and medically
∗ Corresponding author at: Department of Biochemistry, Saurashtra University,
ajkot, Gujarat, India. Tel.: +91 281 2578507x489; fax: +91 281 2585083.
E-mail addresses: gsdave@sauuni.ernet.in, gsdspu@gmail.com (G.S. Dave).
ttp://dx.doi.org/10.1016/j.btre.2014.05.003
215-017X/© 2014 Published by Elsevier B.V. This is an open access article under the CC (http://creativecommons.org/licenses/by-nc-nd/3.0/).
useful antibiotics and 60% of antibiotics used in agriculture [10].
Major types of antibiotics produced by Streptomyces are amino-
glycosides, anthracyclins, glycopeptides, -lactams, macrolides,
nucleosides, peptides, polyenes, polyethers, and tetracyclines [11].
In spite of the availability of new antimicrobial products, the
development of new antimicrobial agents, preferably naturally
occurring with novel mechanisms of action, is an urgent thera-
peutic need with increase in drug resistant pathogens, and the
magnitude at which these pathogens are transmitted among peo-
ple. Even though much work on the terrestrial actinomycetes is
done but still especially soil remains the richest versatile source for
new and clinically important antibiotics [12].
In view of the above, in the present study, we have described
the morphological, biochemical and phylogenetic characteristics
of isolated alkaliphilic strain Streptomyces werraensis.  Strain was
further explored for production of antimicrobial compounds.
2. Methods2.1. Sample collection and isolation of microorganism
Soil sample was  collected from the Saurashtra University cam-
pus, Rajkot, Gujarat, India. 1 g soil was  suspended in 9 ml  of sterile
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ouble distilled water. Diluted aliquots (0.1 ml) of 10−2, 10−3,
0−4 and 10−5 were spread on the isolation plates containing
tarch caseinagar, oatmeal agar and actinomycetes isolation agar
Himedia, Mumbai) containing combination of penicillin and chlor-
mphenicol. Plates were incubated at 28 ◦C for 7–14 days. Stock
ulture of isolated strain was preserved in 15% glycerol (v/v) at 4 ◦C.
.2. Physiological, biochemical and cultural characteristics
Morphological, biochemical and cultural characteristics of the
solated strain was studied as described in Bergey’s manual. Carbo-
ydrate utilization was determined by growth on carbon utilization
edium supplemented with 1% carbon sources at 30 ◦C. Temper-
ture range for growth was determined on actinomycete isolation
gar by growing at different temperatures (10, 15, 20, 30, 37, 42
nd 50 ◦C). Hydrolysis of starch was evaluated on starch agar media.
eduction of nitrate was determined and all cultural characteristics
ere recorded after six days of incubation.
.3. In vitro screening of isolates for antimicrobial activity
Pure isolates were spot inoculated on actinomycetes isolation
gar medium (Hi-Media, Mumbai) and plates were incubated at
0 ◦C for six days followed by inversion for 40 min  over chloroform
n fumehood. Colonies were then covered with a 0.6% agar layer of
utrient agar medium (for bacteria), previously seeded with two
ram positive (Bacillus subtilis and Staphylococcus aureus) and two
ram negative strains (Escherichia coli and Serretia sp.) to evaluate
ntimicrobial activity.
.4. Phylogenetic analysis
The 16SrRNA gene was ampliﬁed with primers
orward (5′-GAGTTTGATCC TGGCTCA-3′) and reverse (5′-
CGGCTACCTTGTTACGACTT-3′). Ampliﬁed PCR product was
equenced and nucleotide sequence was matched using BLAST
rogram. Phylogenetic tree was constructed using neighbor-
oining method [13]. Sequence of the isolate was submitted to
enBank (Accession ID: JQ964039).
.5. Submerged fermentation
Seed culture media for submerged fermentation with following
omposition (g/l) was used: soybean meal 30, glucose 10, glyc-
rol 10, (NH4)2HPO4 1, (NH4)2SO4 3.5, CaCO3 5.10% of inoculum
as added in 100 ml  production media with composition: (g/l):
ucrose 35, yeast extract 15.0, NaCl 4, KH2PO4 3, K2HPO4 2 and
nSO4 1. Inoculated cultures were grown in a rotary shaker at
00 rpm at 30 ◦C for seven days. Biomass was separated by centrifu-
ation and ﬁlter sterilized supernatant was used for extracellular
ntimicrobial activity. 100 l of supernatant of each isolate was
dministrated in each well. Plates were incubated at 37 ◦C and zone
f inhibition was measured after 24 h of incubation. Optimization
f carbon and nitrogen sources i.e. glucose, starch, lactose, sucrose,
alactose, fructose, maltose and xylose were added as individual
arbon sources in production media at 1% concentration. Casein,
east extract, peptone, soya bean meal, NH4Cl, NH4NO3, NaNO3
nd urea were provided separately as a nitrogen sources into the
roduction medium.
.6. Extraction and partial puriﬁcation of antimicrobial
etabolitesBiomass was separated from growth medium by centrifugation
t 4000 rpm for 10 min. Crude antimicrobial compound produced in
ulture was extracted through manual shaking with equal volumey Reports 1–2 (2014) 2–7 3
of chloroform or ethyl acetate or methanol in a separating funnel.
The ﬁltered supernatant was  extracted by chloroform in ratio of
1:1 (v/v). The yellow colored residual crude active compound was
puriﬁed by thin layer chromatography (TLC) in a running solvent
system of methanol and chloroform. Two  fractions with different Rf
values recovered from TLC plates were dissolved in 10% Dimethyl-
sulfoxide (DMSO) and bioassayed against the test microorganisms.
Puriﬁcation of this crude compound was carried out in column
chromatography technique on silica gel (MerckLtd. India) using
chloroform-methanol (Rankem Ltd. India) gradient (11:3) as run-
ning solvent system. Extract were collected and characterized by
FTIR and HPLC analysis.
2.7. Antimicrobial testing activity
Antimicrobial activity of isolated active metabolite was studied
by agar well diffusion method. Freshly grown colonies of bacterial
strains were inoculated into 25 ml  of nutrient broth (NB, Hi-media)
in a shaking water bath for 4–6 h until turbidity reached to 0.5O.D.
(660 nm). Final inoculum was  adjusted to 5 × 108 CFUml−1to each
agar plate. The plates were incubated at 37 ◦C and the zones of inhi-
bition were measured after 24 h. Pure solvent served as a control.
2.8. HPLC and FTIR analysis of antibiotic sample
Extracted puriﬁed antibiotic fractions were characterized
by HPLC (High Performance Liquid chromatography) and FTIR
(Fourier Transform infrared resonance) chromatography. HPLC
of bioactive metabolite was determined at 215 nm with mobile
phase of Acetonitrile-Methanol-0.2 M Ammonium acetate-Water
(45:10:10:35) in C18 column. FTIR spectra of the puriﬁed antibi-
otic fractions were analyzed after homogenization of the sample
with KBR. The FTIR spectra were recorded on SHIMADZU AUX 220
spectrometer in the range of 4000–400 cm−1.
3. Results and discussion
Present study focuses on isolation of potent antibiotic producing
alkaliphilic actinomycetes. Fifty actinomycetes strains were iso-
lated from ten soil samples collected from the different places of
Saurashtra University, Rajkot, Gujarat, India. Among the isolated
pure strains, only one actinomycetes culture, BCI-1 was  found to
produce wide spectrum of antimicrobial activities (Gram-positive
and Gram-negative bacteria). BCI-I was  characterized by 16srRNA
sequencing and identiﬁed as S. werraensis.  In general, Streptomyces
are primarily saprophytic and are best known microorganism from
soils where they contribute signiﬁcantly to the turnover of com-
plex biopolymers and antibiotics [14]. The isolated culture BCI-1
inhibited none of fungal test organisms; however, isolate BCI-1
inhibited all four bacterial test organisms, suggesting a prokaryotic
inhibitory preference.
IsolateBCI-1 was aerobic, Gram positive and showed aerial
mycelia with sporangium (sporophore). The vegetative mycelium
showed cream-light, brown color while the aerial mycelium
showed light gray color. Culture on examination in light microscopy
showed characteristics like ﬂexuous sporophores arising from the
aerial mycelium which ﬁts to be in the genus Streptomyces [15].
Strain was  mesophilic in nature and grows up to 40 ◦C, 2.5% NaCl
concentration with pH 9 as optimum. Organism could utilize glu-
cose, arabinose, mannitol, maltose and sucrose as the carbon source
along with acid production; however, xylose, galactose and fruc-
tose were utilized without the production of acid. The physiological
and biochemical characteristics of the strains (BCI-1) are shown in
Table 1.
The 16S rRNA gene partial sequence of the isolate was com-
pared with the nucleotide sequences of other Streptomyces strains
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Table  1
Physiological and biochemical characteristics of strains Streptomyces werraensis
(BCI-1).
Characteristics Streptomyces werraensis(BCI-1)
Colony characteristics Gram Positive, Aerial Mycelia
Pigmentation Cream light brown color
Anaerobic growth −−
pH 9.0
Sugar fermentation with acid production
Glucose ++
Maltose ++
Sucrose ++
Mannitol ++
Sugar fermentation without acid production
Xylose −−
Galactose −−
Fructose −−
Triple sugar iron (TSI) agar +ve
Starch hydrolysis +ve
Lipid hydrolysis −ve
Indole production −ve
Methyl red −ve
Voges–Proskauer (V–P) −ve
Citrate utilization −ve
Gelatin hydrolysis +ve
Catalase +ve
Phenyl alanine −ve
Nitrate reduction −ve
Dehydrogenase −ve
Hemolysin production +ve
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Table 2
Effect of different carbon and nitrogen sources on antibiotic production.
Media components Media pH after
fermentation
Antibacterial activity
(Zone in mm)
S. aureus E. coli
Production Media(PM) 9.0 ± 0.3 0.0 0.0
Carbon sources
PM + Glucose 8.9 ± 0.23 9 ± 1.0 10 ± 2
PM  + Starch 8.7 ± 0.3 11 ± 2.0 11 ± 2.0
PM  + Lactose 9.2 ± 0.2 10 ± 1.0 11 ± 2.0
PM  + Sucrose 9.0 ± 0.05 21 ± 2.0 20 ± 2.0
PM  + Galactose 8.6 ± 0.2 15 ± 1.0 14 ± 2.0
PM  + Fructose 8.8 ± 0.3 17 ± 2.0 15 ± 2.0
PM  + Maltose 9.12 ± 0.05 12 ± 1.0 10 ± 1.0
PM  + Xylose 9.23 ± 0.05 8 ± 2.0 9 ± 2.0
PM + Glycerol 8.6 ± 0.1 10 ± 2.0 9 ± 2.0
PM + Glycerol + Sucrose 9.0 ± 0.2 15 ± 2.0 13 ± 1.0
Nitrogen sources
Casein 8.8 ± 0.15 9 ± 2.0 5 ± 1.0
Yeast extract 9.0 ± 0.25 24.0 ± 2.0 22.0 ± 2.0
Peptone 9.1 ± 0.3 11 ± 2.0 10 ± 2.0
Soya bean meal 9.1 ± 0.2 13 ± 2.0 12 ± 2.0
NH4Cl 8.5 ± 0.05 8 ± 1.0 6 ± 1.0
NH4NO3 8.4 ± 0.1 7 ± 2.0 7 ±2.0
stationary phase that conﬁrmed the compound to be a secondary
metabolite in nature. In the present study glucose does not sup-
port the production of antibacterial compounds, which was  inCasein hydrolysis +ve
Ammonia production +ve
etrieved from the NCBI GenBank database and phylogenetic posi-
ion of the strain was determined using the neighbor-joining
ethod. The strain showed maximum homology (99%) with Strep-
omyces spp. DRL 337(NCBI Accession No. FJ853207). Therefore,
n basis of the microscopic, macroscopic, biochemical, physiolog-
cal and 16S rRNA gene sequence, the designated isolate BCI-1was
ound to be S. werraensis (JQ964039) of genus Streptomyces.
Results from TLC showed two fractions with different Rfvalues.
he fraction with Rf value 0.385 and UV max at 241.99 nm
n chloroform exhibits antimicrobial activity against all the test
icroorganisms. The fraction with Rf value 0.256 and UV max
t 278 nm in ethyl acetate showed higher inhibition toward
ram positive organism compared to Gram negative organisms.
he reason of different sensitivity between Gram-positive and
ram-negative bacteria could be ascribed to the morphological dif-
erences between these microorganisms [16]. For further studies,
he broad spectrum active fraction collected from chloroform was
haracterized. Partial puriﬁcation process was carried out through
olumn chromatography packed with silica gel. The puriﬁed frac-
ion was soluble in ethyl acetate, chloroform and DMSO whereas
paringly soluble in water.
Growth medium supplementation with different carbon and
itrogen sources showed better antibiotic production. The strain S.
erraensis was cultivated in fermentation medium supplemented
ith various carbon and nitrogen sources and their effect on growth
s well as antimicrobial activity was studied. The strain was  able
o grow in all the tested carbon sources with maximum antibi-
tic production in medium supplemented with sucrose (Table 2).
he result shows that antibiotic production was higher in medium
aving sucrose (3.5%) as carbon source. The antibiotic production
s largely inﬂuenced by nature of carbon and nitrogen sources as
eported by Vilches and group [17]. The growth as well as antibiotic
roduction decreases with either increase or decrease of sucrose
oncentration. Our result are similar to that of bioactive metabo-
ite production using reported Streptomyces tanashiensis strain A2D
y Singh et al. [18] where sucrose supported the production ofNaNO3 8.6 ± 0.3 5 ± 1.0 4 ± 1.0
Urea 8.6 ± 0.2 8 ± 1.0 8 ± 1.0
bioactive metabolites. The production started during mid-Fig. 1. (A) Effect of pH on bioactive metabolite production. (B) Effect of temperature
on  bioactive metabolite production.
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Table  3
Minimum inhibitory concentration of crude extract.
Crude extract MIC  (g/ml)
B. subtilis S. aureus E. coli Serretia GSD2 sp.
Chloroform 3.0 g/ml 1.0 g/ml ≤0.5 g/ml 2.0 g/ml
Ethyl acetate >20 g/ml 7.5 g/ml 5.0 g/ml >20 g/ml
Methanol >20 g/ml 10 g/ml >20 g/ml >20 g/ml
Table 4
Minimum Inhibitory Concentration of isolated compound.
Isolated compound MIC  (g/ml)
B. subtilis S. aureus E. coli Serretia GSD2 sp.
0.5 g
5.0 g
0.0 g
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Ethyl  acetate 15 g/ml 
Methanol >20 g/ml 1
ontradiction with the previous reports in strains Streptomyces san-
anensis strain RJT-1 [19], Streptomyces kanamyceticus M27  [20]
here the glucose facilitates the production of secondary metabo-
ites. The depleted growth in the glucose supplemented media was
ight be due to high concentration of glucose increases the cell
rowth and leads to inhibition of antimicrobial agent production
nd also repress the secondary metabolism [21,22]. Out of both
rganic and inorganic nitrogen sources, maximum antibiotic pro-
uction was found in the medium consists of yeast extract (1.5%) as
itrogen source, our results are in lines with the previous reports
f optimum antibiotic production using organic nitrogen sources
or better yield [23,24].
S. werraensis strain grew and secreted antibiotic in range 2–5%
aCl with optimal concentration at 2.5%. However, further above
% salt concentration, strain was grown without production of
ntibiotic. BCI-1 secreted the antibiotic in wide range of pH 6–9,
hile poor growth was evident at pH values below pH 6.0. The
aximum growth as well as antimicrobial compound production
as obtained at pH 9. The result strongly depicts the alkaline
ature of organism which supports the previous reports [18,25,26].
he S. werraensis was found to be in mesophilic in nature as it
hows narrow range of incubation temperature for relatively good
rowth and antibiotic production. S. werraensis secreted antibiotic
fter 7 days of incubation at 30 ◦C which was found optimum for
aximum growth and antibiotic production (Fig. 1). It has been
eported that the environmental factors like temperature, pH, salt
oncentration and incubation have profound inﬂuence on antibi-
tic production [27–29]. Production of antibiotic was found to
ig. 2. FT-IR spectra of the partially puriﬁed bioactive compound showing 96% structura
ed  color – Crude compound). (For interpretation of the references to color in this ﬁgure /ml ≤0.5 g/ml 2.0 g/ml
/ml 2.5 g/ml >20 g/ml
/ml 15.0 g/ml >20 g/ml
be highest at pH 9, whereas at pH 10 antibiotic production was
completely depleted. The results are comparable with some Strep-
tomyces species recorded to produce antibiotics against bacteria,
fungi and yeast at alkaline Ph [18]. The results are in contrast to
the result reported using Streptomyces sp. ERI-3 for antimicrobial
production [30]. Our ﬁndings supports fact that generally alkaline
environment is more suitable for the growth of Streptomyces and
thus production of antimicrobial compound [16]. Antibiotic pro-
duction was optimum at 2.5% NaCl with in signiﬁcant decrease at 3
and 4%. The strain of Saha and group reported that the antimicrobial
potential of actinomycetes isolate grew in the presence of 20% (w/v)
NaCl, while 5% salt concentration was  found to be optimum for
antibiotic production [31]. S. werraensis secreted the antibiotic with
optimum temperature at 30 ◦C. This temperature range is reported
as adequate for good production of secondary metabolites is narrow
temperature range for example, 5–10 ◦C (Tables 3 and 4).
The FT-IR spectrum of the partially puriﬁed antimicrobial com-
pound produced by S. werraensis,  showed 96% structural similarity
with that of the Erythromycin A (screened form the Library match)
(Fig. 2).
In  HPLC analysis, two  peaks were found to be merged with
that of standard after merging the two  chromatograms. Further
test chromatogram was screened for the library match build in
Shimadzu HPLC (Fig. 3a and b). On the basis of the standard
erythromycin and standard build in library for identiﬁcation of
the antimicrobial agent, it could be stated that the antimicro-
bial compound is suggestive of being belonging to erythromycin
antibiotic. For partial puriﬁcation, separation of antibiotic has
l resemblance with that of erythromycin hydrate (Blue color – Erythromycin Std.,
legend, the reader is referred to the web  version of the article.)
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een tried by thin-layer chromatography using a solvent system
f chloroform and methanol (24:1, v/v) [32,33]. The compound
s freely soluble in chloroform, ethyl acetate, n-butanol, ace-
one, ethyl alcohol, methanol but sparingly soluble in water;
imilar results were recorded earlier [33,34]. The characteriza-
ion of partial puriﬁed compounds was carried out by FTIR and
PLC analysis. Infrared spectra showed a primary imine func-
ion (3469–3451 cm−1), amine function (3040, 673 cm−1), alkane
roups (2958–2853 cm−1, 1466–1461 cm−1) (C C) of aromatic ring
1639–1495 cm−1), p-di substituted benzene (831 and 801 cm−1)
nd secondary alcohol function (3469–3451, 1370−1, 408, 1192−1,
98, 1040–1111 cm−1). HPLC analysis showed conﬁrmation
hrough similar max of standard, constructed library of reference
tandards by Shimadzu Inc. with isolated antibiotic, similar charac-
erization of compound was reported earlier by many investigators
25,35].
Currently, increased resistant among pathogens against the
vailable antimicrobial compounds, search of novel natural source
or production of antimicrobial compounds is important. Present
nvestigation highlights importance of media and cultural condi-
ions for production of antimicrobial compound with its structural
haracterization. chromatogram of the partially puriﬁed antibiotic.
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